US biopharma essentials could get paddled in ugly lame duck session
This article was originally published in SRA
Executive Summary
While Congress managed to pass a continuing resolution at the last hour to keep the US federal government running six more months, it adjourned at the end of last week leaving critical business unfinished until after the November elections, most notably, preventing the $1.2 trillion across-the-board sequestration spending cuts from kicking in come January1-3.